Basic Information
Cephalexin
50090-5196
Regulatory Information
50090-5196
ANDA210221
C73584
November 26, 2021
USA
These highlights do not include all the information needed to use CEPHALEXIN FOR ORAL SUSPENSION safely and effectively. See full prescribing information for CEPHALEXIN FOR ORAL SUSPENSION CEPHALEXIN for oral suspension Initial U.S. Approval: 1971
Human Prescription Drug Label
3
Company Information
830016429
Active Ingredients
SODIUM BENZOATE
Code: OJ245FE5EU
Class Code: IACT
METHYLCELLULOSE (400 MPA.S)
Code: O0GN6F9B2Y
Class Code: IACT
SILICON DIOXIDE
Code: ETJ7Z6XBU4
Class Code: IACT
STRAWBERRY
Code: 4J2TY8Y81V
Class Code: IACT
SUCROSE
Code: C151H8M554
Class Code: IACT
METHYLCELLULOSE (15 MPA.S)
Code: NPU9M2E6L8
Class Code: IACT
XANTHAN GUM
Code: TTV12P4NEE
Class Code: IACT
FD&C RED NO. 40
Code: WZB9127XOA
Class Code: IACT
Active Moieties
CEPHALEXIN ANHYDROUS
Code: 5SFF1W6677